The Current Ratio as of December 2025 (TTM) for Candel Therapeutics, Inc. (CADL) is 8.25

According to Candel Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.25. This represents a change of 45.35% compared to the average of 5.67 of the last 4 quarters.

Candel Therapeutics, Inc. (CADL) Historical Current Ratio (quarterly & annually)

How has CADL Current Ratio performed in the past?

The mean historical Current Ratio of Candel Therapeutics, Inc. over the last ten years is 12.26. The current 8.25 Current Ratio has changed 6.63% with respect to the historical average. Over the past ten years (40 quarters), CADL's Current Ratio was at its highest in in the September 2021 quarter at 20.68. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Candel Therapeutics, Inc. (CADL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Candel Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Candel Therapeutics, Inc. (CADL) Average Current Ratio

How has CADL Current Ratio performed in the past?

The current Current Ratio of Candel Therapeutics, Inc. (CADL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Candel Therapeutics, Inc. (CADL) Current Ratio vs. Peers

How is CADL’s Current Ratio compared to its peers?

Candel Therapeutics, Inc.’s Current Ratio is greater than Mereo BioPharma Group plc (8.13), less than Immutep Limited (11.69), greater than Capricor Therapeutics, Inc. (4.37), greater than ProQR Therapeutics N.V. (3.76), less than Contineum Therapeutics, Inc. Class A Common Stock (29.07), greater than Genelux Corporation (4.20), greater than Aldeyra Therapeutics, Inc. (2.86), greater than Kyverna Therapeutics, Inc. (5.39), greater than Editas Medicine, Inc. (2.77), greater than Cabaletta Bio, Inc. (3.60),

Build a custom stock screener for Candel Therapeutics, Inc. (CADL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Candel Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Candel Therapeutics, Inc. (CADL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Candel Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.